Erythromycin resistance in Finland declines after reduction in macrolide use

Am J Health Syst Pharm. 1997 Nov 1;54(21):2436-7. doi: 10.1093/ajhp/54.21.2436.
No abstract available

Publication types

  • News

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Drug Resistance, Microbial
  • Drug Utilization / trends
  • Erythromycin / therapeutic use*
  • Finland
  • Humans
  • Streptococcal Infections / drug therapy*
  • Streptococcus pyogenes / drug effects*

Substances

  • Anti-Bacterial Agents
  • Erythromycin